These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 12195121

  • 1. Effects of nebivolol and atenolol on small arteries and microcirculatory endothelium-dependent dilation in hypertensive patients undergoing isometric stress.
    Arosio E, De Marchi S, Prior M, Zannoni M, Lechi A.
    J Hypertens; 2002 Sep; 20(9):1793-7. PubMed ID: 12195121
    [Abstract] [Full Text] [Related]

  • 2. Nebivolol reverses endothelial dysfunction in essential hypertension: a randomized, double-blind, crossover study.
    Tzemos N, Lim PO, MacDonald TM.
    Circulation; 2001 Jul 31; 104(5):511-4. PubMed ID: 11479245
    [Abstract] [Full Text] [Related]

  • 3. Effects of nebivolol and atenolol on insulin sensitivity and haemodynamics in hypertensive patients.
    Poirier L, Cléroux J, Nadeau A, Lacourcière Y.
    J Hypertens; 2001 Aug 31; 19(8):1429-35. PubMed ID: 11518851
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparative effects of nebivolol and atenolol on blood pressure and insulin sensitivity in hypertensive subjects with type II diabetes.
    Fogari R, Zoppi A, Lazzari P, Mugellini A, Lusardi P, Preti P, Van Nueten L, Vertommen C.
    J Hum Hypertens; 1997 Nov 31; 11(11):753-7. PubMed ID: 9416986
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Beta-blocker treatment of patients with diastolic heart failure and arterial hypertension. A prospective, randomized, comparison of the long-term effects of atenolol vs. nebivolol.
    Nodari S, Metra M, Dei Cas L.
    Eur J Heart Fail; 2003 Oct 31; 5(5):621-7. PubMed ID: 14607201
    [Abstract] [Full Text] [Related]

  • 8. Differential effects of nebivolol and atenolol on transmitral diastolic filling parameters in patients with essential hypertension.
    Tuncer M, Guntekin U, Gunes Y, Gumrukcuoglu HA, Eryonucu B.
    Adv Ther; 2008 Jun 31; 25(6):619-26. PubMed ID: 18563311
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Nebivolol in high-risk, obese African Americans with stage 1 hypertension: effects on blood pressure, vascular compliance, and endothelial function.
    Merchant N, Searles CD, Pandian A, Rahman ST, Ferdinand KC, Umpierrez GE, Khan BV.
    J Clin Hypertens (Greenwich); 2009 Dec 31; 11(12):720-5. PubMed ID: 20021529
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Medium-term effects of beta-blockade on left ventricular mechanics: a double-blind, placebo-controlled comparison of nebivolol and atenolol in patients with ischemic left ventricular dysfunction.
    Rousseau MF, Chapelle F, Van Eyll C, Stoleru L, Hager D, Van Nueten L, Pouleur H.
    J Card Fail; 1996 Mar 31; 2(1):15-23. PubMed ID: 8798100
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinical pharmacodynamics of nebivolol: new evidence of nitric oxide-mediated vasodilating activity and peculiar haemodynamic properties in hypertensive patients.
    Zanchetti A.
    Blood Press Suppl; 2004 Oct 31; 1():17-32. PubMed ID: 15587108
    [Abstract] [Full Text] [Related]

  • 17. Effects of nebivolol and atenolol on central aortic pressure in hypertensive patients: a multicenter, randomized, double-blind study.
    Redón J, Pascual-Izuel JM, Rodilla E, Vicente A, Oliván J, Bonet J, Torguet JP, Calaforra O, Almirall J.
    Blood Press; 2014 Jun 31; 23(3):181-8. PubMed ID: 24059690
    [Abstract] [Full Text] [Related]

  • 18. A comparison of atenolol and nebivolol in isolated systolic hypertension.
    Dhakam Z, Yasmin, McEniery CM, Burton T, Brown MJ, Wilkinson IB.
    J Hypertens; 2008 Feb 31; 26(2):351-6. PubMed ID: 18192850
    [Abstract] [Full Text] [Related]

  • 19. Nebivolol: endothelium-mediated vasodilating effect.
    Ritter JM.
    J Cardiovasc Pharmacol; 2001 Dec 31; 38 Suppl 3():S13-6. PubMed ID: 11811387
    [Abstract] [Full Text] [Related]

  • 20. Nebivolol vs atenolol and placebo in essential hypertension: a double-blind randomised trial.
    Van Nueten L, Taylor FR, Robertson JI.
    J Hum Hypertens; 1998 Feb 31; 12(2):135-40. PubMed ID: 9504355
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.